Related Experiment Videos
Gene expression patterns that characterize advanced stage serous ovarian cancers
Johnathan M Lancaster1, Holly K Dressman, Regina S Whitaker
1Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA.
Journal of the Society for Gynecologic Investigation
|January 7, 2004
Summary
Gene expression patterns in advanced serous ovarian cancer were identified using microarray analysis. Immune function genes significantly correlated with patient survival, suggesting a role in cancer virulence and potential therapeutic targets.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Serous ovarian cancer is a leading cause of cancer death in women.
- Identifying molecular markers for advanced stages is crucial for prognosis.
Purpose of the Study:
- To identify gene expression patterns characterizing advanced stage serous ovarian cancers.
- To correlate gene expression with patient survival outcomes.
Main Methods:
- Genome-wide expression analysis of 31 advanced ovarian cancers and 3 normal samples.
- Validation of key gene expression using quantitative real-time polymerase chain reaction (QRT-PCR).
Main Results:
- Gene expression patterns successfully distinguished ovarian cancers from normal tissue.
- Distinct gene expression profiles correlated with patient survival ( <2 years vs. >7 years).
- Insulin-like growth factor binding protein 2 (IGFBP2) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression showed significant correlation with array data.
Conclusions:
- Global gene expression analysis can identify prognostic markers for ovarian cancer.
- Immune response genes are strongly associated with ovarian cancer survival, indicating their role in disease virulence.
- Further studies with larger cohorts and advanced arrays may refine predictive genetic signatures for therapeutic guidance.